-+ 0.00%
-+ 0.00%
-+ 0.00%

MBX Biosciences Appoints Peter Radovich to Board of Directors

PUBT·11/09/2026 21:03:23
Listen to the news
MBX Biosciences Appoints Peter Radovich to Board of Directors
  • MBX Biosciences appointed Peter Radovich, Mirum Pharmaceuticals’ president and chief operating officer, to its board in October 2026.
  • Jeff Held became chief legal officer in September 2026, bringing over 30 years’ experience, including leadership roles at Zenas BioPharma and Deciphera Pharmaceuticals.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MBX Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611091601PRIMZONEFULLFEED9872769) on November 09, 2026, and is solely responsible for the information contained therein.